CVE-2023-40279
Path Traversal in Openclinic Ga Project Openclinic Ga 5.247.01
Raw vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:NCVSS and EPSS are reproduced from their sources (NVD, FIRST EPSS). Risk Priority is our own derived reading, not an NVD score.
Summary
CVE-2023-40279 is a high-severity Path Traversal (CWE-22) vulnerability in Openclinic Ga Project Openclinic Ga. Its CVSS base score is 7.5 (High).
Operationally, exploitation aligns with the MITRE ATT&CK technique Data Obfuscation (T1001); ranked in the top 11% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
The strongest mitigations our analysis identified map to AC-3 (Access Enforcement) and SI-10 (Information Input Validation) — see the control section below for these in your framework.
Deeper analysis AI-assisted summary
Synthesised by an AI model from the NVD description and linked references — a reading aid, not an authoritative source.
OpenClinic GA version 5.247.01 contains a path traversal vulnerability (CWE-22) that allows an unauthenticated remote attacker to supply an arbitrary directory path through the Page parameter of a GET request to main.do. The flaw received a CVSS 3.1 score of 7.5, reflecting network attackability, low complexity, and high confidentiality impact with no required privileges or user interaction.
An attacker can therefore retrieve files outside the intended web root, exposing sensitive configuration data, source code, or other restricted content stored on the server. The published proof-of-concept report demonstrates successful traversal without authentication, confirming that any reachable instance is directly exposed to information disclosure.
EPSS scores have remained near 0.20 with only a negligible peak-to-current difference, indicating limited observed exploitation interest since disclosure. No vendor advisory or patch information appears in the referenced project pages or reports.
OWASP Top 10 for Web (2025)
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2023-44872
Vulnerability Data
An issue was discovered in OpenClinic GA 5.247.01. An attacker can perform a directory path traversal via the Page parameter in a GET request to main.do.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise Techniques
CVEs Like This One
Affected Assets
Mitigating Controls
Control response
—
—
—
V5.3.2
Mitigating Controls (NIST 800-53 r5) AI
Enforces the intended directory access authorizations that path traversal would otherwise bypass.
Input validation directly neutralizes special path elements before pathname construction occurs.
Least privilege reduces the impact of any unauthorized file access obtained via traversal.
Mitigating Controls (NIST CSF 2.0) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→CSF cross-walk (authority under review) — links open the control.
Patching/maintenance can remediate known path-traversal flaws in deployed software (partial prevention of exploitability) but does nothing to stop the coding defect from being introduced in the first place.
PR.AA-05 defines and reviews access policies but does not address code-level pathname neutralization, so neither direction prevents CWE-22.
Mitigating Controls (ISO/IEC 27001:2022 Annex A) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→ISO cross-walk (authority under review) — links open the control.